loratadine has been researched along with Obesity in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We focused on maternal race/ethnicity and five maternal risk factors: obesity, use of folic acid-containing multivitamins, opioid analgesics, selective serotonin reuptake inhibitors, and loratadine because of their prevalence of use and some reports of associations with major birth defects." | 3.81 | Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures. ( Arth, A; Canfield, MA; Dawson, AL; Parker, SE; Razzaghi, H; Reefhuis, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasheva, OY | 1 |
| Tsoy Nizamutdinova, I | 1 |
| Hargrove, L | 1 |
| Gobbell, C | 1 |
| Troyanova-Wood, M | 1 |
| Alpini, SF | 1 |
| Pal, S | 1 |
| Du, C | 1 |
| Hitt, AR | 1 |
| Yakovlev, VV | 1 |
| Newell-Rogers, MK | 1 |
| Zawieja, DC | 1 |
| Meininger, CJ | 1 |
| Alpini, GD | 1 |
| Francis, H | 1 |
| Gashev, AA | 1 |
| Dawson, AL | 1 |
| Razzaghi, H | 1 |
| Arth, A | 1 |
| Canfield, MA | 1 |
| Parker, SE | 1 |
| Reefhuis, J | 1 |
2 other studies available for loratadine and Obesity
| Article | Year |
|---|---|
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
Topics: Adipose Tissue; Animals; Fatty Liver; Insulin Resistance; Lipids; Loratadine; Lymphatic Vessels; Mal | 2019 |
Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures.
Topics: Adult; Analgesics, Opioid; Anti-Allergic Agents; Case-Control Studies; Congenital Abnormalities; Eth | 2015 |